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The present study examines the effect of concanavalin A (Con A) on
the blood insulin and glucose levels of rats. Male and female rats
treated with Con A (62.5-500 µg/kg) for three days showed a dose- and
time-dependent hyperinsulinemia that lasted more than 48 h. Male rats
were more sensitive to Con A. Thus, 6 h after treatment with Con A the
circulating insulin levels in male rats had increased by 85% (control:
10.2 ± 0.9 mU/l and Con A-treated: 18.8 ± 1 mU/l) compared to only
38% (control: 7.5 ± 0.2 mU/l; Con A-treated: 10.3 ± mU/l) in females.
An identical response was seen after 12 h. Con A (250 µg/kg)
produced time-dependent hypoglycemia in both sexes but more pro-
nounced in males. There was no correlation between the hypoglyce-
mia and hyperinsulinemia described above. The Con A-induced hy-
perinsulinemia in rats of both sexes was abolished in gonadectomized
animals (intact males: +101 ± 17% vs orchiectomized males: -5 ± 3%;
intact females: +86 ± 23% vs ovariectomized females: -18 ± 7.2%).
Pretreating intact male and female rats with human chorionic gonad-
otropin also significantly inhibited the Con A-induced hyperinsuline-
mia. Estradiol (10 µg/kg, im) significantly blocked the Con A-induced
increase in circulating insulin in male rats (101 ± 17% for controls vs
32 ± 5.3% for estradiol-treated animals, P<0.05) while testosterone
(10 mg/kg, im) had no similar effect on intact female rats. Pretreating
Con A-injected rats with opioid antagonists such as naloxone (1 mg/
kg, sc) and naltrexone (5 mg/kg, sc) blocked the hyperinsulinemia
produced by the lectin in males (control: +101 ± 17% vs naloxone-
treated: +5 ± 14%, or naltrexone-treated: -23 ± 4.5%) and females
(control: +86 ± 23% vs naloxone-treated: +21 ± 20%, or naltrexone-
treated: -18 ± 11%). These results demonstrate that Con A increases
the levels of circulating insulin in rats and that this response is opioid-
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Introduction
Plant lectins are proteins capable of bind-
ing to carbohydrates on mammalian cells
and membranes. Such binding can lead to a
variety of effects including cell agglutina-
tion (1), modification of enzymes or recep-
tors on the cell surface (2-5), stimulation of
cell growth (6,7), and various hormone-like
responses (8,9).
Concanavalin A (Con A) is a glucose/
mannose-binding plant lectin isolated from
jack bean (Canavalia ensiformis) seeds that
binds extensively to mammalian cell sur-
faces (10) and exhibits multiple in vitro insu-
lin-like effects (11,12). Thus, Con A stimu-
lates glucose oxidation and hexose transport
(13), inhibits epinephrine-stimulated lipoly-
sis in isolated adipocytes (14) and inhibits
insulin binding to intact adipocytes and liver
cell membranes (12,15).
Lectins and related toxic seed proteins may
share common pharmacological and biochemi-
cal properties, as has been shown for seeds of
the castor bean (Ricinus communis), the jequiriti
bean (Abrus precatorius) (16) and kintoki beans
(Phaseolus vulgaris) (17).
Although Con A and canatoxin (CNTX),
a toxic protein isolated from Canavalia
ensiformis seeds, are structurally distinct (for
a review, see Ref. 18), both substances in-
duce platelet aggregation (19,20), trigger his-
tamine secretion from peritoneal mast cells
(21-23), and induce paw edema (24,25) and
neutrophil chemotaxis in the peritoneal cav-
ity of rats (26-28).
The administration of CNTX to rats raises
circulating insulin levels (29) and produces
hormonally regulated blood glucose alter-
ations (30). Several of the effects described
for this toxin (31,32), including hyperin-
sulinemia (29), are modulated by the endog-
enous opioid system. A long-lasting hypogly-
cemia is the main effect produced by CNTX
in rats (33,34). The increased insulin levels
and consequent hypoglycemia seen in these
animals suggested that the toxin may act
upon pancreatic islet ß-cells. This hypoth-
esis has been confirmed by the observation
that isolated rat pancreatic islets secrete in-
sulin when exposed to CNTX (35).
The present study examines the effect of
Con A on the blood insulin and glucose
levels of rats. The involvement of opioids
and a possible sex-related, hormone-depend-
ent susceptibility to the effects of the toxin
were also investigated.
Material and Methods
Male and female Wistar rats (200-250 g)
were used. All experiments were done be-
tween 1:00 p.m. and 4:00 p.m. using rats that
had been individually caged with free access
to food and water for at least 24 h beforehand.
Con A (Sigma Chemical Co., St. Louis,
MO) was dissolved in 0.1 M phosphate
buffer, pH 7.0, and administered sc to the
animals every 24 h for three days. In most
experiments, the dose of Con A was 250 µg/
kg. At the desired time, blood samples were
obtained from one control and one test group
by cardiac puncture under chloral hydrate
(350 mg/kg, ip) anesthesia.
Insulin levels were measured by radioim-
munoassay (RIA) using a commercial kit
(Pharmacia Diagnostics). The assays were
performed in duplicate using 100-µl serum
aliquots. The intra- and inter-assay coeffi-
cients of variation were ≤5.8% and ≤6.5%,
respectively. The results are reported as mU
of insulin per liter of serum or as a percent of
basal levels (taken as 100%). Blood glucose
levels were determined using a glucose oxi-
dase method (36) and the results are reported
as mmol glucose per liter of blood.
Different groups of rats (six animals per
group) were submitted to one of the follow-
ing protocols: group 1 consisted of intact
males and females injected with Con A or
vehicle. Group 2 consisted of gonadecto-
mized males and females injected with Con
A or vehicle solution three weeks after sur-
gery. Group 3 consisted of intact males and
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females pretreated with human chorionic
gonadotropin (hCG) in accordance with the
schedule used by Reich et al. (37). The ani-
mals were pretreated with hCG (40 IU/kg,
im) over a three-day period. Treatment with
Con A or vehicle was initiated 6 h after the
first injection of hCG. Group 4 consisted of
intact males and females pretreated every 72
h with three injections of 0.5 ml of depo-
estradiol (10 µg/kg in corn oil, im) or depo-
testosterone (10 mg/kg in corn oil, im), re-
spectively. In both cases, the schedule de-
scribed by Pomerantz et al. (38) was used.
Treatment with Con A or vehicle solution
was started on the eighth day of hormonal
pretreatment. Group 5 consisted of intact
males and females pretreated with naloxone
(1 mg/kg, sc) or naltrexone (5 mg/kg, sc) 20
min before the administration of Con A or
vehicle solution.
The results are reported as means ± SEM.
Comparison of the means, reported as per-
cent variation, was performed using the
Kruskal-Wallis test. Other means were com-
pared by the Student unpaired t-test. In both
cases, a P value ≤0.05 was considered to be
significant.
Results
Male and female rats treated chronically
with Con A (62.5-500 µg/kg) developed hy-
perinsulinemia. Tables 1 and 2 show that the
phenomenon was dose- and time-depend-
Table 1 - Dose dependence of the hyperinsulinemia induced by Con A in male and female rats.
Con A was injected sc every 24 h over a three-day period. Blood samples for insulin determinations were
obtained 24 h after the last Con A administration. The results are reported as the mean ± SEM for six rats per
group. *P≤0.05 compared to the control group (Student unpaired t-test).
Con A (µg/kg) Females Males
Serum insulin (mU/l) Serum insulin (mU/l)
Control Treated ∆% Control Treated ∆%
62.5 8.4 ± 0.9 9.5 ± 1.0 +13 10.2 ± 0.5 12.1 ± 2.1* +19
125 8.0 ± 0.7 10.7 ± 0.6* +34 9.4 ± 1.0 12.0 ± 0.3* +27
250 8.2 ± 0.2 15.3 ± 0.3* +86 8.3 ± 0.2 16.8 ± 0.7* +101
500 9.0 ± 1.0 12.1 ± 0.5* +34 11.2 ± 0.6 14.2 ± 0.2* +27
Table 2 - Time course of the hyperinsulinemia induced by Con A in male and female rats.
Con A (250 µg/kg) was injected sc every 24 h over a three-day period. Blood samples for insulin determina-
tions were withdrawn at the times indicated after the last Con A administration. Data are reported as the
mean ± SEM for six rats per group. *P≤0.05 compared to the control group (Student unpaired t-test).
Time (h) Females Males
Serum insulin (mU/l) Serum insulin (mU/l)
Control Treated ∆% Control Treated ∆%
1 10.2 ± 1.0 11.4 ± 1.0 +12 9.2 ± 0.2 11.4 ± 0.4* +24
3 12.2 ± 0.1 14.6 ± 0.2* +20 8.3 ± 0.9 11.3 ± 0.3* +35
6 7.5 ± 0.2 10.3 ± 0.9* +38 10.2 ± 0.9 18.8 ± 1.0* +84
12 9.1 ± 1.0 15.1 ± 1.0* +66 11.4 ± 0.2 25.6 ± 1.0* +124
24 8.2 ± 0.2 15.3 ± 0.3* +86 8.3 ± 0.2 16.8 ± 0.7* +101
48 10.5 ± 0.9 16.0 ± 0.4* +52 9.7 ± 0.2 14.6 ± 0.9* +51
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ent, respectively, and that it lasted for more
than 48 h.
Male rats were more sensitive to the hy-
perinsulinemic effect of Con A (Table 2).
Thus, 6 h after the treatment with Con A
(250 µg/kg), the circulating insulin levels in
males had increased by 85% compared to
only 38% in females. An identical situation
was observed at 12 h (males, +124%; fe-
males, +66%).
The increase in circulating insulin levels
produced by Con A in intact male and fe-
male rats was blocked when the animals
were orchiectomized and ovariectomized,
respectively. Similarly, pretreating intact
male and female rats with hCG significantly
inhibited the Con A-induced hyperinsuline-
mia (Figure 1).
Figure 2 shows that pretreating intact male
rats with estradiol significantly inhibited the
Con A-induced hyperinsulinemia while there
was no significant change in intact female rats
pretreated with testosterone.
Pretreating rats of both sexes with the
opioid antagonists naloxone and naltrexone
inhibited the hyperinsulinemic effect of Con
A (Figure 3).
Male and female rats chronically treated
with Con A (250 µg/kg) showed a biphasic
and time-dependent change in blood glucose
levels (Table 3). The early phase lasted for
approximately 6 h after the last Con A injec-
tion while the late phase continued for up to 24
h and ended by 48 h. In the early phase of the
response male rats exhibited hypoglycemia
while female rats were hyperglycemic. How-
ever, 12 h after the last treatment with Con A
(late phase), a persistent hyperglycemia was
detected in males, while in females there was a
significant but transient decrease in the circu-
lating glucose levels (18%). Thus, rats of both
sexes exhibited hypoglycemia but the response
was more marked in males.
Discussion
The present results demonstrate that Con
Figure 1 - Castration (A) and pretreatment with human chorionic gonadotropin (hCG) (B)
inhibit the hyperinsulinemia produced by Con A in intact male and female rats. Con A (250
µg/kg) was injected sc every 24 h over a three-day period. Blood samples for insulin
determinations were obtained 24 h after the last administration of Con A or vehicle. Each
bar represents the mean ± SEM for six rats per group. The values for the treated animals are
reported as the percent variation relative to the vehicle-treated controls taken as 100%
(males 8.3 mU/l and females 8.2 mU/l). Gonadectomized males and females were injected
with Con A or vehicle three weeks after surgery. Intact males or females received hCG (40
IU/kg) im every 24 h over a three-day period. Treatment with Con A or vehicle was started 6




























Figure 2 - Effect of pretreatment
with estradiol and testosterone
on the hyperinsulinemia pro-
duced by Con A in intact male
and female rats. Male rats were
pretreated with estradiol (OE2,
10 µg/kg) and female rats with
testosterone (T, 10 mg/kg). In
both cases, the hormone was
injected im every 72 h. Treat-
ment with Con A (250 µg/kg) or
vehicle was started on the
eighth day of hormonal pretreat-
ment. The values are reported
as the percent change relative to
the vehicle-treated controls
taken as 100% (males: 8.3 mU/l
and females: 8.3 mU/l). *P≤0.05
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A significantly increased the levels of circu-
lating insulin in rats via a mechanism that
was opioid-dependent and hormonally regu-
lated. Changes in blood glucose levels were
also detected in the lectin-treated rats.
Males were more sensitive than females
to the hyperinsulinemic effect of Con A
(Table 2). In addition, the increase in plasma
insulin levels produced by Con A in rats of
either sex completely disappeared in gona-
dectomized animals (Figure 1A), indicating
that sex hormones play an important role in
this phenomenon. The hyperinsulinemia pro-
duced by Con A was inhibited when rats of
either sex were pretreated with hCG (Figure
1B). Since castration is known to elevate the
circulating gonadotropin concentrations in
male and female animals (39), the increase
in insulin produced by Con A also appears to
be modulated by these hormones.
Morphine and ß-endorphin are powerful
stimuli for insulin secretion (40,41). Several
investigators (42-44) have demonstrated that
the effects of opioid-like peptides, in addi-
tion to being sex related, are also hormonally
regulated. Our findings that the pretreatment
of Con A-injected rats with opioid antago-
nists such as naloxone and naltrexone (45)
completely blocked the hyperinsulinemia
induced by this lectin (Figure 3) are consist-
ent with the foregoing reports.
As described for CNTX (18,29,35), the
Con A-induced hyperinsulinemia may also
have resulted from a secretory action of this
lectin on pancreatic ß-cells. However, this
hypothesis was not supported by our data
showing that male rats are more sensitive
than females to Con A-induced hyperin-
sulinemia (Table 2) since it is well known
that estrogens (46) and progesterone (47)
intensify the secretory response of ß-cells.
Estradiol significantly blocked Con A-in-
duced increase in plasma insulin levels in
male rats while no significant change was
seen in intact females treated with testoster-
one. This is an unusual finding since testos-




















Figure 3 - Naloxone and naltrex-
one inhibit the hyperinsulinemia
induced by Con A in rats. Intact
male and female rats were pre-
treated im with naloxone (NLX,
1 mg/kg) or naltrexone (NTX, 5
mg/kg) 20 min before the injec-
tion of Con A (250 µg/kg) or ve-
hicle. The animals were bled for
insulin determination 24 h after
the last treatment with Con A or
vehicle. The values are reported
as the percent change relative
to vehicle-treated controls taken
as 100% (males, 8.3 mU/l and
females 8.2 mU/l). *P≤0.05 com-
pared to non-pretreated rats
(Kruskal-Wallis test).
Table 3 - Time course of the blood glucose alterations induced by Con A in male and
female rats.
Con A (250 µg/kg) was injected sc every 24 h over a three-day period. Blood samples
for glucose determinations were obtained at the times indicated after the last Con A
administration. The results are reported as the mean ± SEM for six rats per group.
*P≤0.05 compared to the control group (Student unpaired t-test).
Time (h) Females Males
Blood glucose (mmol/l) Blood glucose (mmol/l)
Control Treated ∆% Control Treated ∆%
1 9.0 ± 0.2 10.6 ± 0.2* +18 10.2 ± 0.3 8.5 ± 0.2* -17
3 8.8 ± 0.4 10.8 ± 0.3* +23 9.0 ± 0.1 6.0 ± 0.3* -33
6 9.1 ± 0.1 10.8 ± 0.1* +19 8.9 ± 0.2 7.4 ± 0.2* -17
12 8.8 ± 0.2 7.2 ± 0.1* -18 8.1 ± 0.1 9.4 ± 0.1* +16
24 8.4 ± 0.2 8.6 ± 0.1 -2 10.5 ± 0.1 13.6 ± 0.2* +29
48 9.0 ± 0.3 8.1 ± 0.5 -10 11.0 ± 0.3 10.6 ± 0.1 -4
sponse of pancreatic ß-cells in response to
glucose (48).
The regulatory mechanism that maintains
the systemic glucose balance involves hor-
monal, neural, and autoregulatory factors.
Hypoglycemia is only an indication that the
rate of glucose efflux from the circulation
exceeds that of glucose influx. The time
course of the hyperinsulinemia (Table 2)
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duced by Con A in rats of both sexes was not
positively correlated with each other, indi-
cating that these two responses were not
necessarily related. However, it is interest-
ing to note that the blood glucose alterations
induced by the lectin in rats, like hyperin-
sulinemia, are sex-related, hormonally regu-
lated and opioid-dependent (49), suggesting
that a common pathophysiological mech-
anism is involved in these events.
The present data demonstrate that Con A
significantly increased blood insulin levels
in rats via an opioid-dependent, hormonally
regulated pathway. Exactly how sex hor-
mones and opioids are involved in this hy-
perinsulinemia is currently under investiga-
tion in our laboratory.
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